GrayMatters Health Ltd.
GrayMatters Health is transforming mental healthcare by providing evidence-based technology that enhances standard-of-care therapies. Their flagship product, Prism for PTSD, is the first FDA-cleared self-neuromodulation device designed to help patients manage PTSD symptoms through innovative brain activity regulation techniques.
Industries
N/A
Nr. of Employees
small (1-50)
GrayMatters Health Ltd.
Products
Prism for PTSD
A prescription neurofeedback therapy system combining EEG headset hardware and application software that uses an fMRI‑informed EEG biomarker to guide self‑neuromodulation training as an adjunctive treatment for PTSD.
Prism for PTSD
A prescription neurofeedback therapy system combining EEG headset hardware and application software that uses an fMRI‑informed EEG biomarker to guide self‑neuromodulation training as an adjunctive treatment for PTSD.
Services
On‑site installation and staff training enabling clinic teams to begin treating patients same day; supports operation by non‑physician personnel.
Partnerships and collaborative research with academic and clinical institutions to test, validate and extend EEG‑informed biomarkers and neurofeedback protocols.
On‑site installation and staff training enabling clinic teams to begin treating patients same day; supports operation by non‑physician personnel.
Partnerships and collaborative research with academic and clinical institutions to test, validate and extend EEG‑informed biomarkers and neurofeedback protocols.
Expertise Areas
- Biomarker development for brain activity (EEG‑fMRI modeling)
- Neurofeedback and neuromodulation protocols
- Clinical trial design and multicenter study execution
- Clinical outcome assessment and validation
Key Technologies
- EEG‑based neurofeedback
- Simultaneous EEG–fMRI acquisition
- fMRI‑informed EEG biomarker modeling (EFP)
- Advanced statistical modeling and machine learning
News & Updates
GrayMatters Health continues to broaden patient access of Prism for PTSD across the US.
GrayMatters Health expands access to its FDA-cleared Prism for PTSD treatment for veterans and civilians.
GrayMatters Health wins the Edison Gold Award for its innovative PTSD treatment.
A study highlights the efficacy of Prism for PTSD in alleviating chronic PTSD symptoms.
GrayMatters Health's Prism for PTSD received recognition as a groundbreaking category-changer to improve lives for the better.
GrayMatters Health was recognized as a Most Innovative Company by Fast Company.
GrayMatters Health continues to broaden patient access of Prism for PTSD across the US.
GrayMatters Health expands access to its FDA-cleared Prism for PTSD treatment for veterans and civilians.
GrayMatters Health wins the Edison Gold Award for its innovative PTSD treatment.
A study highlights the efficacy of Prism for PTSD in alleviating chronic PTSD symptoms.
GrayMatters Health's Prism for PTSD received recognition as a groundbreaking category-changer to improve lives for the better.
GrayMatters Health was recognized as a Most Innovative Company by Fast Company.